House Dust Mite Allergy Market to Surge USD 5 Billion, with Excellent CAGR of 13% by 2030
The data, information, statistics, facts and figures covered in the large scale Global House Dust Mite Allergy Market business report lends a hand to Healthcare industry in maximizing or minimizing the production of goods depending on the conditions of demand. The market research report contains lot of features to offer for Healthcare industry which includes general market conditions, trends, inclinations, key players, opportunities, and geographical analysis. The widespread Global House Dust Mite Allergy Market report provides comprehensive explanation of market definition, market segmentation, competitive analysis and key developments in the HEALTHCARE industry. All this data aids Healthcare industry to take better steps to get their strategies better to trade goods and services.
The top notch Global House Dust Mite Allergy Market report studies and evaluates market drivers, market restraints, challenges, opportunities and key developments in the market. SWOT analysis has been used throughout the report which helps emphasize on the global key manufacturers, market definition, description and analysis of the market competition landscape. It makes effortless for Healthcare industry to visualize what is already available in the market, what market anticipates, the competitive environment, and what should be done to surpass the competitor. This results into actionable ideas, better decision-making and better business strategies.
Data Bridge Market Research analyses a growth rate in house dust mite allergy market in the forecast period 2023-2030. The expected CAGR of house dust mite allergy market is tend to be around 13% in the mentioned forecast period. The market was valued at USD 1.88 billion in 2022, and it would grow upto USD 5 billion by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Download PDF Sample Report (Including Graphs, Charts, and List of Figures) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-house-dust-mite-allergy-treatment-market&Shri
As per WHO records of all types of respiratory allergies, around 70% allergic reactions are related with house dust mites. The incidence of allergic rhinitis accounts for approximately 10-25%, globally. Additionally, as per the World Health Organization (WHO), in 2020, it was reported that about 70% of allergic reactions are caused because of house dust mite allergen.
Market Definition
Dust mite allergy is a type of allergic reaction caused by dust mites present in house environments. House dust mites are tiny bugs with a very adaptive habitat and can survive in any climatic condition. Some people with strong immune systems do not respond to these mites, but people affected by these witness symptoms such as hay running nose, cough, fever, and others. Numerous people also experience conditions such as sinus infections, allergy rhinitis, and asthma.
Drivers
- Increasing Drug Approvals
There are different drug approvals by different drug organizations that are helping in boosting the market growth. For instance, in February 2018, Stallergenes Greer and Shionogi & Co., Ltd. received the marketing approval of Actair. It is an allergy immunotherapy drug used to treat house dust mite (HDM) induced allergic rhinitis in Japan. Stallergenes Greer partnered with Shionogi & Co., Ltd. and announced New Drug Application submission for the drug in January 2017. This approval will provide an effective treatment for house dust mite (HDM) induced allergic rhinitis in Japan and will enlarge the business of both the pharmaceutical companies. Furthermore, Merck & Co., Inc. received the U. S. FDA approval in 2017 for Odactra, an anti-allergy drug used to treat house dust mite-induced nasal inflammation in adults. The drug is widely available in oral dosage form and is administered sublingually. This novel drug will deliver a quality treatment to people suffering from house dust mite induced rhinitis and enlarges the business of the company.
Opportunities
- Growing Demand of Prescription-Based Drugs
The prescription-based drugs increase the market growth resulting in nearly three-fifths of the market, and is expected to maintain its leadership status during the forecast period 2023-2030, due to increase in occurrence of house dust mite allergy diseases and numerous initiatives taken by government and private organizations to spread awareness about different allergic diseases.
House Dust Mite Allergy Market Scope and Segmentation
| REPORT METRIC | DETAILS |
| Forecast Period | 2023-2030 |
| Base Year | 2022 |
| Historic Years | 2021 (Customizable to 2015 – 2020) |
| Quantitative Units | Revenue in USD Billion, Volumes in Units, Pricing in USD |
| Segments Covered | Diagnosis (Skin Prick Test (SPT), Specific IgE Blood Test, Others), Therapy Type (Medication, Immunotherapy, Nasal Irrigation, Others), Route of Administration (Oral, Nasal, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) |
| Countries Covered | U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
To Gain More Insights into the Market Analysis, Browse the Summary of the Research Report@ https://www.databridgemarketresearch.com/reports/global-house-dust-mite-allergy-treatment-market?Shri
Key players operating in the house dust mite allergy market include:
- Shionogi & Co., Ltd (Japan)
- Stallergenes Greer (Switzerland)
- Merck & Co., Inc (U.S.)
- Torii Pharmaceutical Co.,Ltd (Japan)
- Ergomed plc (U.K.)
- Allergy Therapeutics (U.K.)
- DMS Imaging (Belgium)
- HAL Allergy B.V (Netherlands)
- Trio Lifescience Private Limited (India)
- Teva Pharmaceutical Industries Ltd (Israel)
- ICB PHARMA (Poland)
- Bayer AG (Germany)
- Sanofi (France)
- Catalent, Inc (India)
- GSK Plc. (U.K.)
- Merz Pharma (Germany)
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on the product portfolios of the top players in the this research report
- Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and product launches in the market
- Competitive Assessment: In-depth assessment of the market strategies, and geographic and business segments of the leading players in the market
- Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies
Top Key Topics Covered:
- Strategic Imperatives
- Factors Creating Pressure on Growth
- The Strategic Imperative
- Growth Opportunities Fuel the Growth Pipeline Engine
- Research Methodology
- Scope and Segmentation
- Research Context and Scope of Analysis
- Segmentation
- Other Techniques for This Research Report Management
- Growth Opportunity Analysis
- Growth Drivers
- Growth Restraints
- Introduction
- The Impact of the COVID-19 Pandemic and Post
- Future Growth
- Innovation Ecosystem
Continued…
House Dust Mite Allergy Market Scope
Diagnosis
- Skin Prick Test (SPT)
- Specific IgE Blood Test
- Others
Therapy Type
- Medication
- Antihistamines
- Corticosteroids
- Leukotriene Modifiers
- Others
- Immunotherapy
- Nasal Irrigation
- Others
Route of Administration
- Oral
- Nasal
- Others
End User
- Hospitals
- Homecare
- Specialty Clinics
- Others
Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Browse Detailed Summary of Research Report with TOC: https://www.databridgemarketresearch.com/toc/?dbmr=global-house-dust-mite-allergy-treatment-market&Shri
Some of the Most Important Questions Scrutinized in the Business Intelligence Report:
- What are the key growth parameters for this global market during the forecast period?
- Which key players are expected to hold the largest market share over the forecast period?
- Who are the leading vendors and manufacturers in this market?
- What are the key strategies adopted by leading players in the market for business development and geographical expansion?
- Which end-use industries can trigger high demand in the market over the forecast period?
- What are the key segments in this market?
- Which regional player will have anticipated leading the global market in terms of size?
- What is the impact of the novel coronavirus pandemic?
- Which obstacles must new players overcome in order to occupy a major position?
Top DBMR Healthcare Reports:
https://www.databridgemarketresearch.com/reports/global-cardasil-treatment-market?Shri
https://www.databridgemarketresearch.com/reports/global-aestheticcosmetic-lasers-market?Shri
https://www.databridgemarketresearch.com/reports/global-yeast-infection-market?Shri
About Data Bridge Market Research:
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.
Contact Us:-
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- corporatesales@databridgemarketresearch.com
